Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
285 studies found for:    5-HT2A
Show Display Options
Rank Status Study
1 Completed Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors
Condition: Healthy
Interventions: Drug: Citalopram and Pindolol;   Other: Placebo;   Dietary Supplement: Acute tryptophan depletion
2 Recruiting Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing
Condition: Healthy
Interventions: Drug: LSD;   Drug: MDMA;   Drug: Amphetamine;   Drug: Placebo
3 Completed An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression
Condition: Depressive Disorder
Intervention: Drug: MDL100.907
4 Recruiting SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)
Condition: Parkinson's Disease Dementia (PDD)
Interventions: Drug: SYN120;   Drug: Placebo
5 Completed A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377
Condition: Healthy
Intervention: Drug: PF-05212377
6 Completed The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Placebo;   Drug: LSD;   Drug: Ketanserin
7 Completed SPECT Study With SB-773812 In Schizophrenic Patients
Condition: Schizophrenia
Intervention: Drug: SB773812 (risperidone)
8 Completed A Dose-Ranging Study of JNJ-40411813 in Healthy Male Volunteers
Condition: Healthy
Intervention: Drug: JNJ-40411813
9 Completed Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia
Condition: Schizophrenia
Intervention: Drug: quetiapine
10 Completed Neuronal Correlates of Altered States of Consciousness
Condition: Healthy
Interventions: Drug: LSD;   Drug: Placebo
11 Completed Trazodone for SSRI-sexual Dsyfunction
Condition: Sexual Dysfunction
Interventions: Drug: Trazodone;   Drug: Placebo
12 Completed ACP-103 to Treat Parkinson's Disease
Conditions: Parkinson's Disease;   Dyskinesias
Interventions: Drug: Intravenous Levodopa;   Drug: ACP-103
13 Completed Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism
Conditions: Schizophrenia;   Diabetes;   Insulin Resistance
Interventions: Procedure: Glucose clamp technique;   Drug: Amisulpride;   Drug: Olanzapine;   Drug: Placebo
14 Completed Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging
Conditions: Amphetamine-Related Disorders;   Amphetamine Abuse
Intervention: Drug: dexfenfluramine
15 Completed
Has Results
Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)
Conditions: Menopause;   Vasomotor Symptoms
Interventions: Drug: esmirtazapine;   Drug: Placebo
16 Completed Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy
Condition: Post-Operative Pain
Interventions: Drug: VVZ-149 injections;   Drug: Placebo
17 Recruiting A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women
Conditions: PMS;   Hot Flashes
Interventions: Drug: I placebo capsule;   Drug: II RDC 0.3mg capsule;   Drug: III RDC 0.6mg capsule
18 Completed Phase I Study to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection
Condition: Healthy
Interventions: Drug: VVZ-149 Injection;   Drug: placebo
19 Completed Predicting Medication Response in Obsessive Compulsive Disorder
Condition: Obsessive Compulsive Disorder
Interventions: Drug: clomipramine;   Drug: escitalopram;   Drug: duloxetine
20 Completed Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease
Condition: Peripheral Arterial Disease
Interventions: Drug: DP-R202;   Drug: Anplag tab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.